Onco-Innovations (NEOE:ONCO) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NEOE:ONCO Onco-Innovations Ltd NEOE:ONCO
12 GF Score
Price C$0.56
! 2 Warning Signs
View Full Analysis

What is Onco-Innovations FFO?

FFO (Funds from operations) only applies to REITs.

NEOE:ONCO
12GF Score
Onco-Innovations Ltd NEOE:ONCO
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onco-Innovations Business Description

Other Exchanges W1H:Germany
Address 7th Street South West, Suite 1039, Calgary, AB, CAN, T2R 1A5
Onco-Innovations Ltd is a pre-clinical stage biotechnology company working on developing drug candidates that can increase the effectiveness of current cancer treatments.
12GF Score

Get the complete analysis for NEOE:ONCO

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.56
Price